OICHARTS
8 AMThe 8 AM report →

CRL

Charles River Laboratories International, Inc. · XNYS · 131 sessions on record
$295.01▼ −0.95 · −0.3%from $295.96 the session before · Sep 30, 2026 close · end of day
Open
$296.97
High
$298.98
Low
$293.46
Day's range
$5.51.9% of the previous close
VWAP
$296.09close −0.36% from it
Volume, shares
799K0.84× the 20-session average
Traded, $
$236.7M
Trades
17K47 shares per trade
Previous close
$295.96−0.95 to the close
Market cap
$14.08Bat the close of Sep 30
Day range28% of the way up
$293.46$298.98
52-week range95% of the way up
$146.20 May 19$303.31 Aug 27

−2.7% from the high · +100% from the low

Options

No listed options on CRL

Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close
131 sessions on file · from Mar 25
CRL close over the last 126 sessions, with S&P 500 rebased to the first close149.93242.71335.49axis spans 124%S&P 500CRLApr 1Jul 2Sep 30126 sessions from Apr 1 to Sep 30; the price axis spans 124 percent.

Quarterly results

consolidated · latest filed Aug 5, 2026 · SEC filings

Revenue $1.00B, −2.7% on a year earlier; profit −$1.5M, −100% in the Jun 2026 quarter, consolidated.

Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session
Quarterly results of CRL on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue $Revenue YoYProfit $Profit YoYEPS $Market on the day
Jun 2026filed Aug 5$1.00B▼ −2.7%−$1.5M▼ −100%-0.03▲ +1.8%S&P 500 −0.2% · +2.0 pp
Mar 2026filed May 7$995.8M▲ +1.2%−$14.8M▼ −160%-0.30▼ −2.2%S&P 500 +0.8% · −3.1 pp
Dec 2025filed Feb 18$994.2M▼ −0.83%−$276.6M—-5.57—not reached
Sep 2025filed Nov 5$1.00B▼ −0.49%$54.4M▼ −22%1.10—not reached
Jun 2025filed Aug 5$1.03B▲ +0.59%$52.3M▼ −44%1.06▲ +1.8%S&P 500 −0.2% · +2.0 pp
Mar 2025filed May 7$984.2M▼ −2.7%$25.5M▼ −65%0.50▼ −2.2%S&P 500 +0.8% · −3.1 pp
Dec 2024filed Feb 19$1.00B▼ −1.1%−$214.5M▼ −210%-4.17—not reached
Sep 2024filed Nov 5$1.01B▼ −1.6%$69.7M▼ −20%1.33—not reached
By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends
Financial-year results of CRL on the consolidated basis, summed from the quarters filed
YearRevenue $Revenue YoYProfit $Profit YoYEPS $
FY25to Dec 2025$4.02B▼ −0.85%−$144.3M▼ −750%-2.91
FY24to Dec 2024$4.05B▼ −1.9%$22.2M▼ −95%0.20
FY23to Dec 2023$4.13B▲ +3.9%$474.6M▼ −2.4%9.22
FY22to Dec 2022$3.98B▲ +12%$486.2M▲ +24%9.48
FY21to Dec 2021$3.54B▲ +21%$391.0M▲ +7.3%7.60

Fundamentals

consolidated · filings to Jun 2026 · close $295.01 on Sep 30

5.0 times book value, revenue −0.74% over twelve months, market cap $14.08B.

Valuation
Market cap
$14.08Bon Sep 30
Price to earnings
—
Trailing EPS
$-4.80diluted · consolidated · four quarters to Jun 2026
Price to book
5.0consolidated · balance sheet to Jun 2026
Book value a share
$59.48consolidated · balance sheet to Jun 2026
Debt to equity
—
Return on equity
-7.7%trailing profit over average equity · consolidated
Dividend yield
—
Price to sales
3.5market cap over revenue, four quarters to Jun 2026
Shares outstanding
47.7Mon Sep 30
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
$4.00Bfour quarters to Jun 2026
Revenue growth, 12 months
▼ −0.74%against the twelve months before
Revenue 3-year CAGR
▼ −1.4%trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months
−$238.5Mfour quarters to Jun 2026
Profit growth, 12 months
—
Profit 3-year CAGR
—

Shareholding

quarter to Jun 2026 · SEC Form 13F

13F managers hold 230% of shares, FMR LLC the largest at 18%, BlackRock, Inc. 16% and VANGUARD CAPITAL MANAGEMENT LLC 13%, as filed for the quarter to Jun 2026.

Held by 13F managers
230%of shares outstanding
Shares held
108M−2.1% on Mar 2026 among managers filing both
Managers holding
534521 a quarter earlier
Largest holder
18%FMR LLC
Largest 10 holderspercent of shares outstanding · change in shares against the previous quarter
Largest 13F holders of CRL
ManagerSharesOf outstandingValueChange on quarter
FMR LLC8.48M18%$1.92B+1.57M
BlackRock, Inc.7.6M16%$1.72B−121K
VANGUARD CAPITAL MANAGEMENT LLC6.3M13%$1.43B−106K
Invesco Ltd.5.97M13%$1.35B+1.18M
HARRIS ASSOCIATES L P4.48M9.4%$1.02B+176K
VANGUARD PORTFOLIO MANAGEMENT LLC4.42M9.3%$1.00B−167K
Allspring Global Investments Holdings, LLC3.81M8.0%$872.9M−176K
STATE STREET CORP3.73M7.8%$845.6M−18.7K
DIMENSIONAL FUND ADVISORS LP3.3M6.9%$747.7M−8.07K
ARIEL INVESTMENTS, LLC3.01M6.3%$683.2M+124K
Insider tradesSEC Forms 3, 4 and 5 · the latest 10

No open-market insider buying or selling in the last 90 days.

CRL insider trades
InsiderTradeSharesPriceHeld after
Parisotto Shannon MOfficergift · Jun 5, 20261,529$0.009,853
Parisotto Shannon MOfficergift · Jun 5, 20261,529$0.009,680
Girshick BirgitOfficergift · Jun 5, 20263,386$0.0036,013
Girshick BirgitOfficergift · Jun 5, 20263,386$0.0043,803
FOSTER JAMES CDirectorgift · Jun 5, 2026153,361$0.00126,596
FOSTER JAMES CDirectorgift · Jun 5, 202610,000$0.0010,000
FOSTER JAMES CDirectorgift · Jun 5, 202610,000$0.000
FOSTER JAMES CDirectorgift · Jun 5, 202620,000$0.0020,000
FOSTER JAMES CDirectorgift · Jun 5, 202620,000$0.00106,596
FOSTER JAMES CDirectorgift · Jun 5, 2026153,361$0.00155,611

Corporate actions

exchange records

No corporate action on record for CRL yet.

Price history

131 sessions on record · to Sep 30 · end of day

CRL is +4.5% over 20 sessions against the S&P 500's +0.1%, 2.7% below its 52-week high, realised volatility 35% annualised.

Returns against S&P 500longest window first · S&P 500 over the same sessions
Returns of the stock and S&P 500 over six windows, longest first
WindowFrom $CRL %S&P 500 %Difference pp
120 sessionssince Apr 9$175.55▲ +68%▲ +12%+56
60 sessionssince Jul 7$228.67▲ +29%▲ +2.0%+27
20 sessionssince Sep 1$282.33▲ +4.5%▲ +0.11%+4.4
5 sessionssince Sep 23$277.32▲ +6.4%▼ −0.67%+7.1
1 sessionsince Sep 29$295.96▼ −0.32%▼ −0.21%−0.11
Averages of the closeclose against each average
5-session average
$294.57close +0.15% from it
20-session average
$283.87close +3.9% from it
50-session average
$273.49close +7.9% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
$103.4% of the close
Average day's range, 20
$9.43.2% of the close
Volume against 20 sessions
0.84×799K vs 960K average
Volatility and co-movement with S&P 500annualised from daily returns
Realised volatility, 20
35%≈ ±2.2% a session · moved more than that on 5 of 20
Realised volatility, 60
40%≈ ±2.5% a session · moved more than that on 12 of 60
Beta to S&P 500, 60
0.68moved with S&P 500 on 34 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
10 up · 10 downof 20
Last 60 sessions
28 up · 32 downof 60
Best session, 250
▲ +11%Aug 5
Worst session, 250
▼ −9.2%Apr 23

Charles River Laboratories International, Inc. is held by

2 headlines on CRL

latest Sep 30, 2026 · links go to the publisher

Short-sale volume

25 sessions · to Sep 30, 2026

Short sales were 64% of reported volume on Sep 30, 2026, against 47% over the last 25 sessions.

Last 10 sessionsshare of the day's reported volume
CRL daily short-sale volume
SessionShort volumeReported volumeShort share
Sep 30, 2026174K274K63.6%
Sep 29, 2026156K224K69.6%
Sep 28, 2026159K255K62.6%
Sep 25, 2026182K339K53.8%
Sep 24, 2026383K616K62.2%
Sep 23, 2026373K661K56.4%
Sep 22, 2026246K419K58.6%
Sep 21, 2026121K252K48.1%
Sep 18, 2026158K282K56.1%
Sep 17, 2026217K379K57.3%

Filings

SEC EDGAR · newest first
CRL SEC filings
FiledFormReport date
Sep 24, 20268-KSep 24, 2026
Sep 8, 2026SCHEDULE 13G/A—
Aug 27, 20264Aug 25, 2026
Aug 25, 2026144—
Aug 20, 20264Aug 19, 2026
Aug 20, 20264Aug 19, 2026
Aug 20, 20264Aug 18, 2026
Aug 19, 2026144—
Aug 18, 2026144—
Aug 13, 20264Aug 11, 2026
Aug 13, 20264Aug 11, 2026
Aug 13, 2026SCHEDULE 13G—
Aug 11, 2026144—
Aug 11, 2026144—
Aug 11, 20264Aug 10, 2026
Aug 11, 20264Aug 10, 2026
Aug 10, 2026144—
Aug 10, 20264Aug 6, 2026
Aug 10, 20264Aug 6, 2026
Aug 6, 2026144—
Aug 6, 2026144—
Aug 6, 20264Aug 5, 2026
Aug 6, 2026SCHEDULE 13G/A—
Aug 5, 2026144—
Aug 5, 202610-QJun 27, 2026

About Charles River Laboratories International, Inc.

SEC and exchange records
Company
Charles River Laboratories International, Inc.
Exchange
XNYS
SEC CIK
1100682
Sessions on record
131
Price source
End of day · delayed
Computed
1 Oct, 10:36 pm IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.